Revenue
No reported data
Turn Therapeutics Inc. (TTRX)
Price—Loading quote
Net income
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | |
|---|---|---|
| Research & development | $265,570 | $245,956 |
| Operating expenses | $5.9M | $1.8M |
| Operating income | −$5.9M | −$1.8M |
| EBITDAderived | −$5.8M | −$1.7M |
| Net income | −$3.2M | −$1.8M |
| Basic EPSper diluted share | -$0.12 | -$0.07 |
| Diluted EPSper diluted share | -$0.12 | -$0.07 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 12, 2025Form 4 | Chaudhary ZuraizSee Remarks | BuyCommon Stock | 2.5K | $3.50 | $8.8K | 12.5K |
| Nov 24, 2025Form 4 | GOLDEN ARTHUR FDirector | BuyCommon Stock | 9.9K | $3.44 | $33.9K | 60.6K |
| Nov 21, 2025Form 4 | GOLDEN ARTHUR FDirector | BuyCommon Stock | 20.5K | $2.87 | $58.9K | 50.7K |
| Nov 21, 2025Form 4 | Chaudhary ZuraizSee Remarks | BuyCommon Stock | 1.0K | $3.29 | $3.3K | 10.0K |
| Nov 20, 2025Form 4 | Chaudhary ZuraizSee Remarks | BuyCommon Stock | 1.4K | $2.61 | $3.8K | 9.0K |